Jesse McCool is the CEO of GBI Bio. McCool is based in the United States.
Jesse McCool, Ph.D., is an operations executive with more than 25 years of experience in biotechnology and biopharmaceutical development and manufacturing. He previously held senior leadership positions at Lonza Group, Cytovance Biologics, Wheeler Bio, Bionova Scientific, and Our Blood Institute, and served as co-founder and CEO of Wheeler Bio. His expertise spans biologics development, CDMO operations, plasmid DNA manufacturing, monoclonal antibodies, and advanced therapy supply chains.
Recent developments
AI summary of recent coverageRecent coverage has focused on Jesse McCool's leadership appointments at GBI Bio, including promotion to Chief Executive Officer in September 2026 following a prior role as President beginning in January 2026. The headlines highlight McCool's involvement in directing the company's commercial manufacturing expansion and stem-cell production scaling efforts, particularly related to GBI Bio's operations in South Florida.
Summarized from the headlines below; see each source for the full story.
Our coverage
On CEOInsider
No feature yet. When we publish a feature, interview or cover story on Jesse McCool, it will appear here — and tie into the news timeline.
Jesse McCool: FAQ
- Who is Jesse McCool?
- Jesse McCool is the Chief Executive Officer of GBI Bio, based in United States.
- What company does Jesse McCool lead?
- Jesse McCool is CEO of GBI Bio.